We are live on ! Find out more
TIL icon

Instil Bio
TIL

95 hedge funds and large institutions have $577M invested in Instil Bio in 2022 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 34 increasing their positions, 24 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

42% more repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 24

5% more capital invested

Capital invested by funds: $551M → $577M (+$26.1M)

0.01% less ownership

Funds ownership: 4.61% → 4.6% (-0.01%)

3% less funds holding

Funds holding: 98 → 95 (-3)

21% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 14

25% less funds holding in top 10

Funds holding in top 10: 4 → 3 (-1)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $1K

Holders
95
Holders Change
-3
Holders Change %
-3.06%
% of All Funds
1.64%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.05%
New
11
Increased
34
Reduced
24
Closed
14
Calls
–
Puts
$1K
Net Calls
-$1K
Net Calls Change
-$1K

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$5.23M
2
NIP
Nicholas Investment Partners
California
+$2.6M
3
BlackRock
BlackRock
New York
+$2.43M
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$2.3M
5
Charles Schwab
Charles Schwab
California
+$1.4M

Top Sellers

Rank Fund Capital Flow
1
VA
VR Adviser
New York
-$10.8M
2
Renaissance Technologies
Renaissance Technologies
New York
-$1.64M
3
CCM
CAAS Capital Management
New York
-$1.48M
4
ACH
ArrowMark Colorado Holdings
Colorado
-$1.14M
5
UBS AM
UBS AM
Illinois
-$933K
Name Holding Trade Value Shares
Change 		Change in
Stake
N
26
Nuveen
North Carolina
$1.12M -$15.3K -134 -1%
Morgan Stanley
27
Morgan Stanley
New York
$1.1M +$500K +4,373 +63%
AllianceBernstein
28
AllianceBernstein
Tennessee
$985K +$49.2K +430 +4%
D.E. Shaw & Co
29
D.E. Shaw & Co
New York
$853K -$454K -3,968 -31%
VIA
30
Vident Investment Advisory
Georgia
$609K -$77.2K -675 -10%
RhumbLine Advisers
31
RhumbLine Advisers
Massachusetts
$506K +$33.3K +291 +6%
LFCM
32
Long Focus Capital Management
Puerto Rico
$484K – – –
QF
33
QVT Financial
New York
$477K – – –
M&T Bank
34
M&T Bank
New York
$440K -$59.7K -522 -10%
PM
35
Parametrica Management
Hong Kong
$428K +$4.23K +37 +0.8%
HWAM
36
Hennion & Walsh Asset Management
New Jersey
$423K +$124K +1,088 +33%
AA
37
ALPS Advisors
Colorado
$343K -$33.6K -294 -8%
Dimensional Fund Advisors
38
Dimensional Fund Advisors
Texas
$322K +$229K +2,001 +153%
State of Wisconsin Investment Board
39
State of Wisconsin Investment Board
Wisconsin
$287K +$340K +2,969 New
CSS
40
Cubist Systematic Strategies
Connecticut
$249K -$153K -1,341 -34%
TI
41
Trexquant Investment
Connecticut
$241K +$66.1K +578 +30%
Deutsche Bank
42
Deutsche Bank
Germany
$231K +$84.2K +736 +45%
MIM
43
MetLife Investment Management
New Jersey
$210K +$66.5K +581 +37%
New York State Common Retirement Fund
44
New York State Common Retirement Fund
New York
$206K +$1.6K +14 +0.7%
CIC
45
Cornercap Investment Counsel
Georgia
$206K +$243K +2,124 New
GCM
46
Graham Capital Management
Connecticut
$193K -$168K -1,466 -42%
AIG
47
American International Group
New York
$160K +$2.63K +23 +1%
Rockefeller Capital Management
48
Rockefeller Capital Management
New York
$150K +$73.3K +641 +70%
Manulife (Manufacturers Life Insurance)
49
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$143K -$6.41K -56 -4%
EAM
50
Erste Asset Management
Austria
$139K – – –
1
2
3 4 5

TIL Hedge Fund Activity: Q3 2022 in Review

95 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Instil Bio (TIL) for Q3 2022, worth a combined $577M — up 4.7% from $551M a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of TIL and 11 opened new positions — a net loss of 3 holders — while 24 trimmed existing stakes and 34 added.

The largest buyer was Vanguard Group, adding an estimated $5.23M. The largest seller was VR Adviser, cutting an estimated $10.8M.

  • 95 institutional investors held Instil Bio (TIL) as of Q3 2022, down from 98 in Q2 2022.
  • Funds reported $577M of Instil Bio stock for Q3 2022, up 4.7% quarter-over-quarter.
  • 11 funds opened new Instil Bio positions in Q3 2022 and 14 closed out, a net change of -3 holders.
  • The largest Instil Bio buyer in Q3 2022 was Vanguard Group, an estimated $5.23M added.
  • The largest Instil Bio seller in Q3 2022 was VR Adviser, an estimated $10.8M sold.

Based on aggregated 13F filings for Q3 2022.